Leukosite's P2P Acquisition

Leukosite raised a round of funding on December 13, 1999. Investors include Millennium Pharmaceuticals.

Leukosite develops drugs to block disease promoting actions of white blood cells, with potential applications within the areas of cancer, autoimmune and viral diseases.…

Articles about Leukosite's P2P Acquisition: